Stage I-IV lymphoepithelioma of the oropharynx
Showing 1 - 25 of >10,000
Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2
Active, not recruiting
- Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
- +22 more
- External Beam Radiation Therapy
- Orbital Radiation
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage IIA Colorectal Cancer AJCC v8 Trial in San
Completed
- Stage I Colorectal Cancer AJCC v8
- +12 more
- Dietary Intervention
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital
Jan 5, 2023
Breast Cancer, Insomnia Trial (transauricular Vagus Nerve Stimulation)
Not yet recruiting
- Breast Cancer
- Insomnia
- transauricular Vagus Nerve Stimulation
- (no location specified)
Aug 21, 2023
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Quality of Life and Utilities Following Surgical Treatment of
Recruiting
- Rectal Adenocarcinoma
- +13 more
- Quality-of-Life Assessment
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 2, 2023
Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the
Active, not recruiting
- Human Papilloma Virus Infection
- +3 more
- paclitaxel albumin-stabilized nanoparticle formulation
- +8 more
-
Chicago, IllinoisUniversity of Chicago
Mar 2, 2022
Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100
Terminated
- Recurrent Melanoma
- +3 more
- Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
- Laboratory Biomarker Analysis
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,
Active, not recruiting
- Metastatic Melanoma
- +6 more
- Ibrutinib
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 13, 2023
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Natural Killer Cell Therapy
- Temozolomide
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 28, 2022
Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,
Recruiting
- Esophageal Carcinoma
- +16 more
- Educational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)
Terminated
- Estrogen Receptor Positive
- +16 more
- Biopsy of Breast
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022
Postoperative Circulating Tumor DNA Monitoring for Colorectal
Active, not recruiting
- Colorectal Cancer
- Serial ctDNA monitoring
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 28, 2023
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)
Not yet recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Stage IV Lung Cancer
- Carboplatin
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Oct 25, 2023
Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological
Completed
- Stage IIIB Non-Small Cell Lung Cancer AJCC v7
- Stage IV Non-Small Cell Lung Cancer AJCC v7
- Laboratory Biomarker Analysis
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Sep 14, 2022
Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)
Completed
- Melanoma
- Skin Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023
Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)
Completed
- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin
- TAPCells vaccine
-
Santiago, RM, ChileFaculty of Medicine, University of Chile
Nov 21, 2023
Metastatic Melanoma Trial in Boston (Tremelimumab, MEDI3617)
Active, not recruiting
- Metastatic Melanoma
-
Boston, Massachusetts
- +1 more
Mar 22, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +22 more
- Minoxidil
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jun 8, 2022
Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma
Recruiting
- Clinical Stage I Cutaneous Melanoma AJCC v8
- +8 more
- Ipilimumab
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 28, 2022
Stage IV Lung Adenocarcinoma Trial in United States (Certolizumab, cisplatin, pemetrexed)
Completed
- Stage IV Lung Adenocarcinoma
- Certolizumab
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Jan 25, 2023
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Los Angeles (Autologous
Recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
- Pembrolizumab
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022